mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.005 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.006 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.006 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.007 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.007 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |